WallStSmart

Coherent Inc (COHR)vsUSBC, Inc. (USBC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

COHR leads profitability with a 7.1% profit margin vs 0.0%. COHR earns a higher WallStSmart Score of 56/100 (C).

COHR

Buy

56

out of 100

Grade: C

Growth: 7.3Profit: 5.0Value: 5.0Quality: 7.5
Piotroski: 5/9Altman Z: 1.53

USBC

Avoid

21

out of 100

Grade: F

Growth: 4.3Profit: 3.0Value: 5.0Quality: 4.5
Piotroski: 3/9Altman Z: -0.20

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COHR4 strengths · Avg: 8.8/10
EPS GrowthGrowth
73.0%10/10

Earnings expanding 73.0% YoY

Market CapQuality
$83.52B9/10

Large-cap with strong market position

PEG RatioValuation
0.928/10

Growing faster than its price suggests

Revenue GrowthGrowth
20.5%8/10

Revenue surging 20.5% year-over-year

USBC2 strengths · Avg: 10.0/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0910/10

Conservative balance sheet, low leverage

Areas to Watch

COHR4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.534/10

Distress zone — elevated risk

Return on EquityProfitability
4.4%3/10

ROE of 4.4% — below average capital efficiency

Profit MarginProfitability
7.1%3/10

7.1% margin — thin

P/E RatioValuation
204.3x2/10

Premium valuation, high expectations priced in

USBC4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$138.57M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : COHR

The strongest argument for COHR centers on EPS Growth, Market Cap, PEG Ratio. Revenue growth of 20.5% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.

Bull Case : USBC

The strongest argument for USBC centers on Price/Book, Debt/Equity.

Bear Case : COHR

The primary concerns for COHR are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 204.3x leaves little room for execution misses.

Bear Case : USBC

The primary concerns for USBC are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

COHR profiles as a growth stock while USBC is a value play — different risk/reward profiles.

COHR carries more volatility with a beta of 2.05 — expect wider price swings.

COHR is growing revenue faster at 20.5% — sustainability is the question.

USBC generates stronger free cash flow (-7M), providing more financial flexibility.

Bottom Line

COHR scores higher overall (56/100 vs 21/100) and 20.5% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coherent Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a variety of scientific, commercial, and industrial research applications. The company is headquartered in Santa Clara, California.

USBC, Inc.

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

US BioTec, Inc. engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States. The company is headquartered in Gleason, Tennessee.

Want to dig deeper into these stocks?